{"ticker": {"uuid": "04015aa2-76d0-47b2-b1a5-76a2a51af34c", "symbol": "ALC", "name": "Alcon AG", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "Systane Hydration by Alcon Inc. - dry eye relief beyond the pharmacy shelf", "summary": "Alcon Inc.'s Systane Hydration Augentropfen offers dry eye relief with a dual polymer formulation (PEG, propylene glycol) and HP-Guar for sustained moisture. Positioned for daily use and moderate symptoms, it comes in multi-dose and preservative-free single-use vials, contributin", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/systane-hydration-by-alcon-inc-dry-eye-relief-beyond-the-pharmacy-shelf/69771008", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-15T05:12:58", "published_display": "15 Jul 2026 05:12", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc (ALC) Shares Fall 3.1% -- What GF Score of 71 Tells In", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPbjFTcXhmTmpFVk41VDlmRFc3cHBHcmJiVzdBUW1iTXVTclo1VHJXQ3lIV2V0MVp4UWJReFVwUEd5cFRObEFJNmY2X2RranhGa2NfTmRpeXJSWFV2U2d4OFRyNVF6b1VJeHBET2EyRENva0U4N2NjWElxOHpmSDE3ZmJuRURKLU1IU2lsLXAxcG51aUl4bmtTV3Utc2ZYLXg3UVN4VmpR?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-14T22:01:21+00:00", "published_display": "14 Jul 2026 22:01", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Alcon (ALC) is a top value stock for the long term", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPWDhKSXhPZXFuQl83MmdLTHdrb3Nka3A0RWtubUdPM3l2c3NONU5sVmMtVVVWaEFMTDVtLVVNYWhLc3QyTkcwTkREcDdfTk5DeXFpM19rNGpMWjBsRkFnV2dpVUlMWlRCWk5pNHRMdGxidS1KbUtod2FkRlhhcVlvWThFbmpBN0pKLUczWGVsWGx6b1cybGYxLUdhMHY1am9sak9UT1JYMzVjdw?oc=5", "source_name": "MSN", "published_at": "2026-07-14T13:40:02+00:00", "published_display": "14 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon & RxSight Collaborate to Develop Adjustable PCIOL Technology", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/alcon-rxsight-collaborate-develop-adjustable-134000076.html", "source_name": "Zacks", "published_at": "2026-07-13T13:40:00+00:00", "published_display": "13 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Systane Ultra Lubricant Eye Drops by Alcon Inc. - dry-eye relief drives a global franchise", "summary": "Alcon's Systane Ultra Lubricant Eye Drops are a key product for dry, irritated eyes, positioning themselves in the mid-range of the Systane portfolio. The article details its formulation, practical handling, market positioning by doctors, and its crucial role in Alcon's constant ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/systane-ultra-lubricant-eye-drops-by-alcon-inc-dry-eye-relief-drives-a/69760356", "source_name": "ad-hoc-news.de", "published_at": "2026-07-13T12:10:03", "published_display": "13 Jul 2026 12:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ophthalmology Devices Market Report Released, Includes Profiles of EssilorLuxottica, Alcon, Bausch + Lomb, and 20 Others", "summary": "The Ophthalmology Devices Market is projected to grow from $56.61 billion in 2025 to $99.22 billion by 2030, driven by an aging population, increasing eye disorders, and advancements in surgical tools and vision correction technologies. Key market trends include minimally invasiv", "url": "https://uk.finance.yahoo.com/news/ophthalmology-devices-market-report-released-113000400.html", "source_name": "Market source", "published_at": "2026-07-13T11:40:02", "published_display": "13 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook", "summary": "RxSight reported a 20% decline in preliminary Q2 sales, reaching $27 million, but updated its full-year 2026 revenue guidance to $140 million-$160 million, buoyed by a new strategic collaboration with Alcon. The partnership aims to develop adjustable presbyopia-correcting intraoc", "url": "https://es.tradingview.com/news/marketbeat:164cb547e094b:0-rxsight-q2-sales-sink-20-as-alcon-deal-bolsters-2026-outlook/", "source_name": "TradingView", "published_at": "2026-07-12T00:10:44", "published_display": "12 Jul 2026 00:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts Predict a 27.75% Upside in Alcon (ALC): Here's What You Should Know", "summary": "Wall Street analysts predict a 27.75% upside for Alcon (ALC), with a mean price target of $85.03. While price targets are cautioned as potentially misleading, strong agreement among analysts on higher earnings estimates and a Zacks Rank #2 (Buy) suggest a potential upside for the", "url": "https://finance.yahoo.com/markets/stocks/articles/wall-street-analysts-predict-27-135502309.html", "source_name": "Market source", "published_at": "2026-07-09T09:55:00", "published_display": "09 Jul 2026 09:55", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can Alcon Inc. (ALC) Stock Rebound as New Eye Care Products Approach Regulatory Milestones?", "summary": "Alcon Inc. (ALC) is positioned for a potential rebound as new eye care products approach regulatory milestones. Argus maintains a Buy rating, citing ALC's undervalued stock price, improved earnings outlook with projected 10%-13% growth in 2026, and a strong late-stage product pip", "url": "https://www.insidermonkey.com/blog/can-alcon-inc-alc-stock-rebound-as-new-eye-care-products-approach-regulatory-milestones-1797678/", "source_name": "Insider Monkey", "published_at": "2026-07-08T15:11:09", "published_display": "08 Jul 2026 15:11", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs", "summary": "Alcon and RxSight have announced a non-exclusive collaboration to develop adjustable presbyopia-correcting intraocular lenses (PCIOLs). This partnership will combine RxSight\u2019s light-adjustable technology with Alcon\u2019s PCIOL designs to allow surgeons to fine-tune visual outcomes fo", "url": "https://invisionmag.com/alcon-and-rxsight-announce-collaboration-to-develop-adjustable-pciols/amp/", "source_name": "InvisionMag.com", "published_at": "2026-07-08T09:10:33", "published_display": "08 Jul 2026 09:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon collaborates with RxSight to develop adjustable PCIOLs", "summary": "Alcon has announced a collaboration with RxSight to develop adjustable posterior chamber intraocular lenses (PCIOLs). This partnership aims to combine RxSight's expertise in adjustable lens technology with Alcon's market presence to potentially improve visual outcomes for catarac", "url": "https://www.msn.com/en-us/money/general/alcon-collaborates-with-rxsight-to-develop-adjustable-pciols/ar-AA27l0IZ", "source_name": "MSN", "published_at": "2026-07-08T03:10:33", "published_display": "08 Jul 2026 03:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RXST: Collaboration with Alcon and product innovation offset Q2 headwinds, supporting revised 2026 outlook", "summary": "RxSight, Inc. (RXST) announced a new collaboration with Alcon to develop adjustable PC IOLs, aiming to expand innovation and market reach. Despite a Q2 revenue decline due to competitive trialing, the company has revised its 2026 guidance and increased commercial investment, emph", "url": "https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:3720994:0-rxst-collaboration-with-alcon-and-product-innovation-offset-q2-headwinds-supporting-revised-2026-outlook/", "source_name": "TradingView", "published_at": "2026-07-07T14:09:28", "published_display": "07 Jul 2026 14:09", "sentiment": "positive", "sentiment_pct": 67, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon, RxSight Begin Co-Developing Presbyopia-Correcting IOLs", "summary": "Alcon and RxSight have partnered to co-develop adjustable, presbyopia-correcting intraocular lenses (PC-IOLs). This collaboration will integrate RxSight\u2019s light-adjustable technology with Alcon\u2019s PCIOL optical designs, aiming to provide surgeons with greater ability to fine-tune ", "url": "https://www.mpo-mag.com/breaking-news/alcon-rxsight-begin-co-developing-presbyopia-correcting-iols/", "source_name": "Medical Product Outsourcing", "published_at": "2026-07-07T13:09:28", "published_display": "07 Jul 2026 13:09", "sentiment": "positive", "sentiment_pct": 87, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon\u2013RxSight (NASDAQ: RXST) deal adds $60M upfront plus milestones, royalties", "summary": "RxSight, Inc. has entered into a license, collaboration, and development agreement with Alcon to co-develop light-adjustable presbyopia-correcting intraocular lenses (PCIOLs). The deal includes a $60 million upfront payment for RxSight, with potential milestones of up to an addit", "url": "https://www.stocktitan.net/sec-filings/RXST/8-k-rx-sight-inc-reports-material-event-a5678d05328e.html", "source_name": "Stock Titan", "published_at": "2026-07-06T23:11:09", "published_display": "06 Jul 2026 23:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ALCON AG - RXSIGHT TO RECEIVE $60 MLN UPFRONT PAYMENT UNDER AGREEMENT", "summary": "Alcon AG has announced that RXSight will receive an upfront payment of $60 million under a new agreement. This payment is a significant financial detail regarding the strategic partnership or transaction between the two companies.", "url": "https://www.moomoo.com/news/flash/22749955/alcon-ag-rxsight-to-receive-60-mln-upfront-payment-under", "source_name": "Moomoo", "published_at": "2026-07-06T20:40:28", "published_display": "06 Jul 2026 20:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon, RxSight partner on adjustable lens technology", "summary": "Alcon and RxSight have announced a non-exclusive collaboration to develop adjustable presbyopia-correcting intraocular lenses for cataract surgery patients. The partnership will combine RxSight\u2019s post-operative light-adjustable technology with Alcon\u2019s lens designs, aiming to allo", "url": "https://ca.investing.com/news/stock-market-news/alcon-rxsight-partner-on-adjustable-lens-technology-93CH-4721611", "source_name": "Investing.com Canada", "published_at": "2026-07-06T20:39:48", "published_display": "06 Jul 2026 20:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon and RxSight team up to develop light-adjustable cataract lenses", "summary": "Alcon and RxSight have announced a non-exclusive collaboration to develop adjustable presbyopia-correcting intraocular lenses (PCIOLs) for cataract surgery. RxSight will receive an upfront payment of $60 million, with potential for an additional $140 million based on milestones, ", "url": "https://www.streetinsider.com/Corporate+News/Alcon+and+RxSight+team+up+to+develop+light-adjustable+cataract+lenses/26735705.html", "source_name": "StreetInsider", "published_at": "2026-07-06T20:39:48", "published_display": "06 Jul 2026 20:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon and RxSight team up on adjustable lenses after cataract surgery", "summary": "Alcon and RxSight have announced a non-exclusive collaboration to develop adjustable presbyopia-correcting intraocular lenses (PCIOLs) for cataract surgery patients. RxSight will receive an upfront payment of $60 million and up to $140 million in milestone payments, with Alcon le", "url": "https://www.stocktitan.net/news/RXST/alcon-and-rx-sight-announce-collaboration-to-develop-adjustable-pcio-m63uwd44z80k.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:39:47", "published_display": "06 Jul 2026 20:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon focuses on eye care growth as investors watch long-term strategy", "summary": "Alcon Inc. continues to expand its surgical and vision care business, focusing on product range, technology platforms, and professional training. The company's strategy leverages structural trends like aging populations and increasing screen use, which drive demand for eye care s", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/alcon-focuses-on-eye-care-growth-as-investors-watch-long-term-strategy/69707989", "source_name": "AD HOC NEWS", "published_at": "2026-07-06T18:39:48", "published_display": "06 Jul 2026 18:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Alcon AG \u2013 SIX:ALC", "summary": "This article provides financial information for Alcon AG (SIX:ALC), specifically focusing on its forward price-to-sales ratio. It briefly lists various financial data points and indicates that the content on this particular metric is \"Made by humans.\"", "url": "https://www.tradingview.com/symbols/SIX-ALC/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T17:39:48", "published_display": "06 Jul 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon focuses on ophthalmic growth as investor interest builds", "summary": "Alcon Inc. is attracting investor attention due to its strong position as a global leader in eye care, driven by an aging population and increasing prevalence of eye conditions. The company's diversified portfolio includes surgical devices, implants, and vision care products, add", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/alcon-focuses-on-ophthalmic-growth-as-investor-interest-builds/69702188", "source_name": "AD HOC NEWS", "published_at": "2026-07-06T06:11:13", "published_display": "06 Jul 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon stock holds its footing. Focus turns to the eye-care model.", "summary": "Alcon's stock performance is analyzed, highlighting its stability due to its ophthalmology and vision-care business model. The article emphasizes the company's product mix in cataract surgery tools, contact lenses, and eye-health products, appealing to investors looking for recur", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/alcon-stock-holds-its-footing-focus-turns-to-the-eye-care-model/69699875", "source_name": "AD HOC NEWS", "published_at": "2026-07-05T19:11:06", "published_display": "05 Jul 2026 19:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon focuses on eye care growth amid global demand", "summary": "Alcon Inc. is expanding its surgical and vision care franchises due to increasing global demand for ophthalmic treatments. The company's strategy emphasizes innovation, a broad portfolio, and geographic expansion, supported by its diversified revenue streams from medical devices ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/alcon-focuses-on-eye-care-growth-amid-global-demand/69694856", "source_name": "AD HOC NEWS", "published_at": "2026-07-05T09:09:20", "published_display": "05 Jul 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc. focuses on eye care growth amid global demand", "summary": "Alcon Inc. is a leading eye care company that is expanding its surgical and vision care businesses due to increasing global demand for ophthalmic products. The company focuses on medical devices and consumables for chronic eye conditions, benefiting from an aging population and c", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/alcon-inc-focuses-on-eye-care-growth-amid-global-demand/69685302", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-04T06:39:45", "published_display": "04 Jul 2026 06:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc. looks to long-term growth as eye-care demand stays solid", "summary": "Alcon Inc. is aiming for long-term growth by leveraging increasing global demand for surgical and vision-care products. The company focuses on innovation, efficiency, and its broad product portfolio, particularly within ophthalmology, driven by aging populations and increasing ey", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/alcon-inc-looks-to-long-term-growth-as-eye-care-demand-stays-solid/69683106", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T20:53:13", "published_display": "03 Jul 2026 20:53", "sentiment": "positive", "sentiment_pct": 70, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc (ALC) Stock Up 4.2% and Still Undervalued -- GF Score: 71/100", "summary": "Alcon Inc (ALC) saw its shares rise by 4.2% to $69.66 on July 2, 2026, yet the stock is still considered undervalued according to its GF Value\u2122 of $91.56. The company boasts a GF Score\u2122 of 71/100, indicating above-average potential for long-term returns, supported by strong valua", "url": "https://www.gurufocus.com/news/8943869/alcon-inc-alc-stock-up-42-and-still-undervalued-gf-score-71100", "source_name": "GuruFocus", "published_at": "2026-07-02T23:09:33", "published_display": "02 Jul 2026 23:09", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc focuses on eye care leadership as investors track long-term growth", "summary": "Alcon Inc, a global eye care specialist, is focusing on expanding its surgical and vision care franchises, balancing innovation, margins, and geographic expansion for long-term growth. The company targets conditions like cataracts and dry eye with its surgical products and offers", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/alcon-inc-focuses-on-eye-care-leadership-as-investors-track-long-term/69673427", "source_name": "AD HOC NEWS", "published_at": "2026-07-02T13:42:15", "published_display": "02 Jul 2026 13:42", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc focuses on eye-care growth as global demand for vision treatment expands", "summary": "Alcon Inc is strategically positioned to benefit from the increasing global demand for eye-care solutions, driven by aging populations and improved access to treatment. The company's diversified portfolio, which includes surgical equipment and contact lenses, and its strong prese", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/alcon-inc-focuses-on-eye-care-growth-as-global-demand-for-vision-treatment/69667789", "source_name": "AD HOC NEWS", "published_at": "2026-07-01T13:39:28", "published_display": "01 Jul 2026 13:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc. (ALC) Stock Analysis: Eyeing A 29.63% Potential Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxONG9jZFZBQU1rQXNTMGhHeGpsLTdRT3FOd3JzRk9IQ1IxRGpielpSV29vTEdwN0k3RktUQTNMcW4xeWVKM0x6U1Y0aG5YRDZId2NXODIzVm5QQ1FSN1BkcktOS0l1emZmazVBNUhsejU3ODEybkJNVlFGMnh0czlLckZsWjhSMnRLU0tDeHBvZVF0NW5Ccy1GT1ppWEtOM3p1TWs0UFBMSVIyRXpsQW01Tg?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evaluating Alcon (SWX:ALC) After Recent Share Price Weakness And Perceived Valuation Gap", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNWkpMdEtJemdLWjRvX0tuRm5PTEp3LVRQTVJkdXNpM2ZFQS1NUFJfOWI2akRLeW5uODFfN01XU1VFVHJQZkFIZkpST1c0UERGeEdlNm1YaFBzQUFQS0FkNHBxaFBqTHVnRUJ4Q0hKZFhaMEdXYmhZMWxXSkdEVHg3VkdzbGxGZ09lbkFrdEl6VDJwQ0I3OVVVTTVBMEs?oc=5", "source_name": "Market source", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Alcon (SWX:ALC) Offer Opportunity After A 26% One Year Share Price Slide?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNcUtaME90RDVsTnJoZmx4RndvRjU0cF82ODJfY0xfU3lZa1UzUWd1OUhtdWFyYVJiRE02NnRrU0E5bWllanJvTUlJZXdKYVVDZG5GQTVlcHIwQlJzcGxsTGpsNFRtNHBTcG43NUxnQi1HZFZZWVhfendNR3ZuMHFjVmlGZTAzeHBZbk1sdEZBR29WTGs?oc=5", "source_name": "Market source", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc. (ALC) Sees Mixed Signals After Q1 Beat and Target Reduction", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQcU1UZnRnZ3laX2pVTThxUVZ0TExfbmVNWlhVaDFNTDgyemJDWWhoSWFlRFRfenphS0FGazc2LVpfaFowTENSM1VYdURHU3owVmlsTjBYbnpmQjBkWm9uM09qdmZxYmtpcVhuT3RHcHlScERPUWljT0R2aWp5WVdMbHZhOHVNTm9PQ3BhdGp4TWhfcTQ?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Q1 2026 slides: EPS beats but revenue miss sparks selloff", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPeHF4R2ZwbXp0Wk9TaGR0MDFVT3Z0ZlE0Q283V0NrQ0J0a1paNGstUHhTRjlDVlRRTW40Xzd0Y3N4WVI1OE1DQkdzMkJjQ3FlOFlkU0pSMWRNTEVpQjdqWnljWU43TG13RnR4anVQU2czU0hsTmVYZlh3YjdvcHpBVEJEZ1RDVFBfSDgweUFKOEltOTZCX2NJWW5COUdJa3U3WnJFeHZ4X1FTYmExUTJsMVNuN1VUVFdRSUI0?oc=5", "source_name": "Investing.com", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Alcon (SWX:ALC) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQcU5aZTdmRGZUV2ZDSTR0S1JGRTI0bXFYM1NTMEhmTF9vVFVKbmpTUGFsdVJmLUlVM0JWY1djVUFYZ2R3d1VPUjViUTZqVUFYUlJOWUc1OG1jdlFOZWhGLTRrY3d4cFZsVVFULUxLc092Y1loejJYTDNFel9JcWVyYTFpUFRhUVNoLUVCX2RvYVZJM2xfUjdVZ3V2R210LUE?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Medical Stocks Lagging Alcon (ALC) This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOQ2RvWThIZnVtQm8wN1NUZjBhelN4dVNLTG8yRGg1ajJKSUVNTkJuVFNXVzBfQzBSTmZ6N1J1WXFPZ3hjcmpMeWR4ZjhOZTMwNGo0S19HeV8zSUpCTDdZUjV5bFdUd09XdEdBVGxnbXdLV2tsRy1BQzduanNacGp1MHEyeVZUZUhDWUNpTlFyM1V3WHdmejhGa1VJbVhGdw?oc=5", "source_name": "Market source", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNZnBoSXJwZ2lvNVNtOWhyUTZCNTRPdkxtRlg5aUlfT1paa1dFOE9ueXJPeDkzbmdNaDdxVlJ3Z2F1TnVKeFpXMnBzcmZuNENkR0NiRW82Rm1BMDRKcjBZYXIxNlpldmlpSWhVakxtZ2JnR3pSRi1JTHlsLTNNeUlFQnF0X05CUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Q4 2025 slides: revenue growth continues, margins compress 160 bps", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQQnBGMjQxRkdkaE9pUXZVR0NLc1EzVDlUVzJ5UnExc0ZMemhLU2xpbnB1a0R3Mnl6YzQwZ180Q0oxLTN6WWJXa3l2U2RScTk3WlZ4NkNhT3NoNDlwNVhtSmFKS3M3a1JFRndfQWU2bnJZWldnS3VMbFV2Sms2Y2l4Mjhpc3loUkRpWkdHdzhKZmU0OTFISjhBS3dCZUVJMnF3b1RpbzNVazJHcUxZTEdzN1lpRl9vaGZ5dnJYektqYXA5NjNyNGc?oc=5", "source_name": "Investing.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc. (ALC) Stock Falls on Q4 2025 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQeGt6MG9RNURrWDNLcnYyMmZHdlRHek1lNGlNeHdsMW03MURpR1FXZzV0WVk3YmMzT2JoeC1INERNWXNwTzdDUm83YkNwNjQtRVlSNkczN1lMenBPbmF6d2FFSUxLQnY0eDVLeWNHcTZOYnVqSkFqb0RFVktZT0tLeXRzYkFCRE1obHBhUXVR?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon shares fall after it cuts guidance and warns of tariff impact", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPQnI2blBka2tJa2Z0b0h5Y1E0NHNrcmJCMVk4RGZIVjI4OERQQlVhOGg0WU5ObUpwM3h1d20ycDNsRnVrVHRvTmMyU1cxWWk1ZS1mdkYtU0JVN1J5c1RLLVlSYzhteHdUVHFjN2JZWTBqVmV4aGN4Tm9QSnE2Tk5QeTBOUUl2YTFnbi1qOWxaYmNyQWJtenVaWld4eUt2cUdP?oc=5", "source_name": "Reuters", "published_at": "2025-08-20T07:00:00+00:00", "published_display": "20 Aug 2025 07:00", "sentiment": "negative", "sentiment_pct": 5, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eyecare company Alcon's shares plunge on revised 2025 outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOMnZyLWRrczBhWmgyQzVJd3NyYW5XY1Byc0pDVDYzQkg4aXRRZDVmZGNpTlJocWFPY2U0UkdjQS1jZ0J6dTkwT1JBX2hsdGpiTTN0UnZnLUR4TGY2N1dPUEpZTjBKclMtQVQzbzBuZkRYT1hUTkpNOXZ6OU1wUnFWTV82cjN0UTNsVjFPU0hvZ29KeE1uWWxKQmc2bjZBek15dDdSNXRpeFpPcUZG?oc=5", "source_name": "Reuters", "published_at": "2025-05-14T07:00:00+00:00", "published_display": "14 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon to pay Johnson & Johnson $199 mln to settle eye-laser cases", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPak5zeGF0RE5RVTRfUUxMVXhZdzFQU0F3NnRuNEswN0Q0MTlITGRMUVdHS2ItN081ZVJGTWhnNWNpMXdGVnozSk5qQkdZVUFBWjB5Z2lmLUJiN2taVlJoVWR4NVJEcEtabW9lLXlpRFpxNWRsUHR3cU5hRmxhUWJqV3VrR01xTkdjTEw2SW5BYkN0SDFXbXItY0ZMOWM5LUU?oc=5", "source_name": "Reuters", "published_at": "2023-02-13T08:00:00+00:00", "published_display": "13 Feb 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc.: Target Price Consensus and Analysts Recommendations | ALC | CH0432492467", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE1KdlI1UVhhbE9QdVMyWF90UkZfNjFiSlZPSXByM29qU0p4ME83MHEyMmtTZzlheXlVOGxreFktT0ZQX0xGUkxJTTh2dEJyVGxKQ25PT2RNR28xcjNCUDZnU2lLbkFxNVlOU29aNTMxdDhvbV8zUDhyYzVyTGM?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-19T09:06:48+00:00", "published_display": "19 Aug 2020 09:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Systane Hydration by Alcon Inc. - dry eye relief beyond the pharmacy shelf", "summary": "Alcon Inc.'s Systane Hydration Augentropfen offers dry eye relief with a dual polymer formulation (PEG, propylene glycol) and HP-Guar for sustained moisture. Positioned for daily use and moderate symptoms, it comes in multi-dose and preservative-free single-use vials, contributin", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/systane-hydration-by-alcon-inc-dry-eye-relief-beyond-the-pharmacy-shelf/69771008", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-15T05:12:58", "published_display": "15 Jul 2026 05:12", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc (ALC) Shares Fall 3.1% -- What GF Score of 71 Tells In", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPbjFTcXhmTmpFVk41VDlmRFc3cHBHcmJiVzdBUW1iTXVTclo1VHJXQ3lIV2V0MVp4UWJReFVwUEd5cFRObEFJNmY2X2RranhGa2NfTmRpeXJSWFV2U2d4OFRyNVF6b1VJeHBET2EyRENva0U4N2NjWElxOHpmSDE3ZmJuRURKLU1IU2lsLXAxcG51aUl4bmtTV3Utc2ZYLXg3UVN4VmpR?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-14T22:01:21+00:00", "published_display": "14 Jul 2026 22:01", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Alcon (ALC) is a top value stock for the long term", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPWDhKSXhPZXFuQl83MmdLTHdrb3Nka3A0RWtubUdPM3l2c3NONU5sVmMtVVVWaEFMTDVtLVVNYWhLc3QyTkcwTkREcDdfTk5DeXFpM19rNGpMWjBsRkFnV2dpVUlMWlRCWk5pNHRMdGxidS1KbUtod2FkRlhhcVlvWThFbmpBN0pKLUczWGVsWGx6b1cybGYxLUdhMHY1am9sak9UT1JYMzVjdw?oc=5", "source_name": "MSN", "published_at": "2026-07-14T13:40:02+00:00", "published_display": "14 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon & RxSight Collaborate to Develop Adjustable PCIOL Technology", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/alcon-rxsight-collaborate-develop-adjustable-134000076.html", "source_name": "Zacks", "published_at": "2026-07-13T13:40:00+00:00", "published_display": "13 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Systane Ultra Lubricant Eye Drops by Alcon Inc. - dry-eye relief drives a global franchise", "summary": "Alcon's Systane Ultra Lubricant Eye Drops are a key product for dry, irritated eyes, positioning themselves in the mid-range of the Systane portfolio. The article details its formulation, practical handling, market positioning by doctors, and its crucial role in Alcon's constant ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/systane-ultra-lubricant-eye-drops-by-alcon-inc-dry-eye-relief-drives-a/69760356", "source_name": "ad-hoc-news.de", "published_at": "2026-07-13T12:10:03", "published_display": "13 Jul 2026 12:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ophthalmology Devices Market Report Released, Includes Profiles of EssilorLuxottica, Alcon, Bausch + Lomb, and 20 Others", "summary": "The Ophthalmology Devices Market is projected to grow from $56.61 billion in 2025 to $99.22 billion by 2030, driven by an aging population, increasing eye disorders, and advancements in surgical tools and vision correction technologies. Key market trends include minimally invasiv", "url": "https://uk.finance.yahoo.com/news/ophthalmology-devices-market-report-released-113000400.html", "source_name": "Market source", "published_at": "2026-07-13T11:40:02", "published_display": "13 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook", "summary": "RxSight reported a 20% decline in preliminary Q2 sales, reaching $27 million, but updated its full-year 2026 revenue guidance to $140 million-$160 million, buoyed by a new strategic collaboration with Alcon. The partnership aims to develop adjustable presbyopia-correcting intraoc", "url": "https://es.tradingview.com/news/marketbeat:164cb547e094b:0-rxsight-q2-sales-sink-20-as-alcon-deal-bolsters-2026-outlook/", "source_name": "TradingView", "published_at": "2026-07-12T00:10:44", "published_display": "12 Jul 2026 00:10", "sentiment": "positive", "sentiment_pct": 65, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts Predict a 27.75% Upside in Alcon (ALC): Here's What You Should Know", "summary": "Wall Street analysts predict a 27.75% upside for Alcon (ALC), with a mean price target of $85.03. While price targets are cautioned as potentially misleading, strong agreement among analysts on higher earnings estimates and a Zacks Rank #2 (Buy) suggest a potential upside for the", "url": "https://finance.yahoo.com/markets/stocks/articles/wall-street-analysts-predict-27-135502309.html", "source_name": "Market source", "published_at": "2026-07-09T09:55:00", "published_display": "09 Jul 2026 09:55", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can Alcon Inc. (ALC) Stock Rebound as New Eye Care Products Approach Regulatory Milestones?", "summary": "Alcon Inc. (ALC) is positioned for a potential rebound as new eye care products approach regulatory milestones. Argus maintains a Buy rating, citing ALC's undervalued stock price, improved earnings outlook with projected 10%-13% growth in 2026, and a strong late-stage product pip", "url": "https://www.insidermonkey.com/blog/can-alcon-inc-alc-stock-rebound-as-new-eye-care-products-approach-regulatory-milestones-1797678/", "source_name": "Insider Monkey", "published_at": "2026-07-08T15:11:09", "published_display": "08 Jul 2026 15:11", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs", "summary": "Alcon and RxSight have announced a non-exclusive collaboration to develop adjustable presbyopia-correcting intraocular lenses (PCIOLs). This partnership will combine RxSight\u2019s light-adjustable technology with Alcon\u2019s PCIOL designs to allow surgeons to fine-tune visual outcomes fo", "url": "https://invisionmag.com/alcon-and-rxsight-announce-collaboration-to-develop-adjustable-pciols/amp/", "source_name": "InvisionMag.com", "published_at": "2026-07-08T09:10:33", "published_display": "08 Jul 2026 09:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon collaborates with RxSight to develop adjustable PCIOLs", "summary": "Alcon has announced a collaboration with RxSight to develop adjustable posterior chamber intraocular lenses (PCIOLs). This partnership aims to combine RxSight's expertise in adjustable lens technology with Alcon's market presence to potentially improve visual outcomes for catarac", "url": "https://www.msn.com/en-us/money/general/alcon-collaborates-with-rxsight-to-develop-adjustable-pciols/ar-AA27l0IZ", "source_name": "MSN", "published_at": "2026-07-08T03:10:33", "published_display": "08 Jul 2026 03:10", "sentiment": "positive", "sentiment_pct": 70, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RXST: Collaboration with Alcon and product innovation offset Q2 headwinds, supporting revised 2026 outlook", "summary": "RxSight, Inc. (RXST) announced a new collaboration with Alcon to develop adjustable PC IOLs, aiming to expand innovation and market reach. Despite a Q2 revenue decline due to competitive trialing, the company has revised its 2026 guidance and increased commercial investment, emph", "url": "https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:3720994:0-rxst-collaboration-with-alcon-and-product-innovation-offset-q2-headwinds-supporting-revised-2026-outlook/", "source_name": "TradingView", "published_at": "2026-07-07T14:09:28", "published_display": "07 Jul 2026 14:09", "sentiment": "positive", "sentiment_pct": 67, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon, RxSight Begin Co-Developing Presbyopia-Correcting IOLs", "summary": "Alcon and RxSight have partnered to co-develop adjustable, presbyopia-correcting intraocular lenses (PC-IOLs). This collaboration will integrate RxSight\u2019s light-adjustable technology with Alcon\u2019s PCIOL optical designs, aiming to provide surgeons with greater ability to fine-tune ", "url": "https://www.mpo-mag.com/breaking-news/alcon-rxsight-begin-co-developing-presbyopia-correcting-iols/", "source_name": "Medical Product Outsourcing", "published_at": "2026-07-07T13:09:28", "published_display": "07 Jul 2026 13:09", "sentiment": "positive", "sentiment_pct": 87, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon\u2013RxSight (NASDAQ: RXST) deal adds $60M upfront plus milestones, royalties", "summary": "RxSight, Inc. has entered into a license, collaboration, and development agreement with Alcon to co-develop light-adjustable presbyopia-correcting intraocular lenses (PCIOLs). The deal includes a $60 million upfront payment for RxSight, with potential milestones of up to an addit", "url": "https://www.stocktitan.net/sec-filings/RXST/8-k-rx-sight-inc-reports-material-event-a5678d05328e.html", "source_name": "Stock Titan", "published_at": "2026-07-06T23:11:09", "published_display": "06 Jul 2026 23:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ALCON AG - RXSIGHT TO RECEIVE $60 MLN UPFRONT PAYMENT UNDER AGREEMENT", "summary": "Alcon AG has announced that RXSight will receive an upfront payment of $60 million under a new agreement. This payment is a significant financial detail regarding the strategic partnership or transaction between the two companies.", "url": "https://www.moomoo.com/news/flash/22749955/alcon-ag-rxsight-to-receive-60-mln-upfront-payment-under", "source_name": "Moomoo", "published_at": "2026-07-06T20:40:28", "published_display": "06 Jul 2026 20:40", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon, RxSight partner on adjustable lens technology", "summary": "Alcon and RxSight have announced a non-exclusive collaboration to develop adjustable presbyopia-correcting intraocular lenses for cataract surgery patients. The partnership will combine RxSight\u2019s post-operative light-adjustable technology with Alcon\u2019s lens designs, aiming to allo", "url": "https://ca.investing.com/news/stock-market-news/alcon-rxsight-partner-on-adjustable-lens-technology-93CH-4721611", "source_name": "Investing.com Canada", "published_at": "2026-07-06T20:39:48", "published_display": "06 Jul 2026 20:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon and RxSight team up to develop light-adjustable cataract lenses", "summary": "Alcon and RxSight have announced a non-exclusive collaboration to develop adjustable presbyopia-correcting intraocular lenses (PCIOLs) for cataract surgery. RxSight will receive an upfront payment of $60 million, with potential for an additional $140 million based on milestones, ", "url": "https://www.streetinsider.com/Corporate+News/Alcon+and+RxSight+team+up+to+develop+light-adjustable+cataract+lenses/26735705.html", "source_name": "StreetInsider", "published_at": "2026-07-06T20:39:48", "published_display": "06 Jul 2026 20:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon and RxSight team up on adjustable lenses after cataract surgery", "summary": "Alcon and RxSight have announced a non-exclusive collaboration to develop adjustable presbyopia-correcting intraocular lenses (PCIOLs) for cataract surgery patients. RxSight will receive an upfront payment of $60 million and up to $140 million in milestone payments, with Alcon le", "url": "https://www.stocktitan.net/news/RXST/alcon-and-rx-sight-announce-collaboration-to-develop-adjustable-pcio-m63uwd44z80k.html", "source_name": "Stock Titan", "published_at": "2026-07-06T20:39:47", "published_display": "06 Jul 2026 20:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon focuses on eye care growth as investors watch long-term strategy", "summary": "Alcon Inc. continues to expand its surgical and vision care business, focusing on product range, technology platforms, and professional training. The company's strategy leverages structural trends like aging populations and increasing screen use, which drive demand for eye care s", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/alcon-focuses-on-eye-care-growth-as-investors-watch-long-term-strategy/69707989", "source_name": "AD HOC NEWS", "published_at": "2026-07-06T18:39:48", "published_display": "06 Jul 2026 18:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Alcon AG \u2013 SIX:ALC", "summary": "This article provides financial information for Alcon AG (SIX:ALC), specifically focusing on its forward price-to-sales ratio. It briefly lists various financial data points and indicates that the content on this particular metric is \"Made by humans.\"", "url": "https://www.tradingview.com/symbols/SIX-ALC/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T17:39:48", "published_display": "06 Jul 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon focuses on ophthalmic growth as investor interest builds", "summary": "Alcon Inc. is attracting investor attention due to its strong position as a global leader in eye care, driven by an aging population and increasing prevalence of eye conditions. The company's diversified portfolio includes surgical devices, implants, and vision care products, add", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/alcon-focuses-on-ophthalmic-growth-as-investor-interest-builds/69702188", "source_name": "AD HOC NEWS", "published_at": "2026-07-06T06:11:13", "published_display": "06 Jul 2026 06:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon stock holds its footing. Focus turns to the eye-care model.", "summary": "Alcon's stock performance is analyzed, highlighting its stability due to its ophthalmology and vision-care business model. The article emphasizes the company's product mix in cataract surgery tools, contact lenses, and eye-health products, appealing to investors looking for recur", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/alcon-stock-holds-its-footing-focus-turns-to-the-eye-care-model/69699875", "source_name": "AD HOC NEWS", "published_at": "2026-07-05T19:11:06", "published_display": "05 Jul 2026 19:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon focuses on eye care growth amid global demand", "summary": "Alcon Inc. is expanding its surgical and vision care franchises due to increasing global demand for ophthalmic treatments. The company's strategy emphasizes innovation, a broad portfolio, and geographic expansion, supported by its diversified revenue streams from medical devices ", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/alcon-focuses-on-eye-care-growth-amid-global-demand/69694856", "source_name": "AD HOC NEWS", "published_at": "2026-07-05T09:09:20", "published_display": "05 Jul 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc. focuses on eye care growth amid global demand", "summary": "Alcon Inc. is a leading eye care company that is expanding its surgical and vision care businesses due to increasing global demand for ophthalmic products. The company focuses on medical devices and consumables for chronic eye conditions, benefiting from an aging population and c", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/alcon-inc-focuses-on-eye-care-growth-amid-global-demand/69685302", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-04T06:39:45", "published_display": "04 Jul 2026 06:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc. looks to long-term growth as eye-care demand stays solid", "summary": "Alcon Inc. is aiming for long-term growth by leveraging increasing global demand for surgical and vision-care products. The company focuses on innovation, efficiency, and its broad product portfolio, particularly within ophthalmology, driven by aging populations and increasing ey", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/alcon-inc-looks-to-long-term-growth-as-eye-care-demand-stays-solid/69683106", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T20:53:13", "published_display": "03 Jul 2026 20:53", "sentiment": "positive", "sentiment_pct": 70, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc (ALC) Stock Up 4.2% and Still Undervalued -- GF Score: 71/100", "summary": "Alcon Inc (ALC) saw its shares rise by 4.2% to $69.66 on July 2, 2026, yet the stock is still considered undervalued according to its GF Value\u2122 of $91.56. The company boasts a GF Score\u2122 of 71/100, indicating above-average potential for long-term returns, supported by strong valua", "url": "https://www.gurufocus.com/news/8943869/alcon-inc-alc-stock-up-42-and-still-undervalued-gf-score-71100", "source_name": "GuruFocus", "published_at": "2026-07-02T23:09:33", "published_display": "02 Jul 2026 23:09", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc focuses on eye care leadership as investors track long-term growth", "summary": "Alcon Inc, a global eye care specialist, is focusing on expanding its surgical and vision care franchises, balancing innovation, margins, and geographic expansion for long-term growth. The company targets conditions like cataracts and dry eye with its surgical products and offers", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/alcon-inc-focuses-on-eye-care-leadership-as-investors-track-long-term/69673427", "source_name": "AD HOC NEWS", "published_at": "2026-07-02T13:42:15", "published_display": "02 Jul 2026 13:42", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc focuses on eye-care growth as global demand for vision treatment expands", "summary": "Alcon Inc is strategically positioned to benefit from the increasing global demand for eye-care solutions, driven by aging populations and improved access to treatment. The company's diversified portfolio, which includes surgical equipment and contact lenses, and its strong prese", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/alcon-inc-focuses-on-eye-care-growth-as-global-demand-for-vision-treatment/69667789", "source_name": "AD HOC NEWS", "published_at": "2026-07-01T13:39:28", "published_display": "01 Jul 2026 13:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc. (ALC) Stock Analysis: Eyeing A 29.63% Potential Upside", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxONG9jZFZBQU1rQXNTMGhHeGpsLTdRT3FOd3JzRk9IQ1IxRGpielpSV29vTEdwN0k3RktUQTNMcW4xeWVKM0x6U1Y0aG5YRDZId2NXODIzVm5QQ1FSN1BkcktOS0l1emZmazVBNUhsejU3ODEybkJNVlFGMnh0czlLckZsWjhSMnRLU0tDeHBvZVF0NW5Ccy1GT1ppWEtOM3p1TWs0UFBMSVIyRXpsQW01Tg?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Evaluating Alcon (SWX:ALC) After Recent Share Price Weakness And Perceived Valuation Gap", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNWkpMdEtJemdLWjRvX0tuRm5PTEp3LVRQTVJkdXNpM2ZFQS1NUFJfOWI2akRLeW5uODFfN01XU1VFVHJQZkFIZkpST1c0UERGeEdlNm1YaFBzQUFQS0FkNHBxaFBqTHVnRUJ4Q0hKZFhaMEdXYmhZMWxXSkdEVHg3VkdzbGxGZ09lbkFrdEl6VDJwQ0I3OVVVTTVBMEs?oc=5", "source_name": "Market source", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Does Alcon (SWX:ALC) Offer Opportunity After A 26% One Year Share Price Slide?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNcUtaME90RDVsTnJoZmx4RndvRjU0cF82ODJfY0xfU3lZa1UzUWd1OUhtdWFyYVJiRE02NnRrU0E5bWllanJvTUlJZXdKYVVDZG5GQTVlcHIwQlJzcGxsTGpsNFRtNHBTcG43NUxnQi1HZFZZWVhfendNR3ZuMHFjVmlGZTAzeHBZbk1sdEZBR29WTGs?oc=5", "source_name": "Market source", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc. (ALC) Sees Mixed Signals After Q1 Beat and Target Reduction", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQcU1UZnRnZ3laX2pVTThxUVZ0TExfbmVNWlhVaDFNTDgyemJDWWhoSWFlRFRfenphS0FGazc2LVpfaFowTENSM1VYdURHU3owVmlsTjBYbnpmQjBkWm9uM09qdmZxYmtpcVhuT3RHcHlScERPUWljT0R2aWp5WVdMbHZhOHVNTm9PQ3BhdGp4TWhfcTQ?oc=5", "source_name": "Market source", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Q1 2026 slides: EPS beats but revenue miss sparks selloff", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPeHF4R2ZwbXp0Wk9TaGR0MDFVT3Z0ZlE0Q283V0NrQ0J0a1paNGstUHhTRjlDVlRRTW40Xzd0Y3N4WVI1OE1DQkdzMkJjQ3FlOFlkU0pSMWRNTEVpQjdqWnljWU43TG13RnR4anVQU2czU0hsTmVYZlh3YjdvcHpBVEJEZ1RDVFBfSDgweUFKOEltOTZCX2NJWW5COUdJa3U3WnJFeHZ4X1FTYmExUTJsMVNuN1VUVFdRSUI0?oc=5", "source_name": "Investing.com", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Assessing Alcon (SWX:ALC) Valuation After Recent Share Price Weakness", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQcU5aZTdmRGZUV2ZDSTR0S1JGRTI0bXFYM1NTMEhmTF9vVFVKbmpTUGFsdVJmLUlVM0JWY1djVUFYZ2R3d1VPUjViUTZqVUFYUlJOWUc1OG1jdlFOZWhGLTRrY3d4cFZsVVFULUxLc092Y1loejJYTDNFel9JcWVyYTFpUFRhUVNoLUVCX2RvYVZJM2xfUjdVZ3V2R210LUE?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Medical Stocks Lagging Alcon (ALC) This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOQ2RvWThIZnVtQm8wN1NUZjBhelN4dVNLTG8yRGg1ajJKSUVNTkJuVFNXVzBfQzBSTmZ6N1J1WXFPZ3hjcmpMeWR4ZjhOZTMwNGo0S19HeV8zSUpCTDdZUjV5bFdUd09XdEdBVGxnbXdLV2tsRy1BQzduanNacGp1MHEyeVZUZUhDWUNpTlFyM1V3WHdmejhGa1VJbVhGdw?oc=5", "source_name": "Market source", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNZnBoSXJwZ2lvNVNtOWhyUTZCNTRPdkxtRlg5aUlfT1paa1dFOE9ueXJPeDkzbmdNaDdxVlJ3Z2F1TnVKeFpXMnBzcmZuNENkR0NiRW82Rm1BMDRKcjBZYXIxNlpldmlpSWhVakxtZ2JnR3pSRi1JTHlsLTNNeUlFQnF0X05CUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Q4 2025 slides: revenue growth continues, margins compress 160 bps", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQQnBGMjQxRkdkaE9pUXZVR0NLc1EzVDlUVzJ5UnExc0ZMemhLU2xpbnB1a0R3Mnl6YzQwZ180Q0oxLTN6WWJXa3l2U2RScTk3WlZ4NkNhT3NoNDlwNVhtSmFKS3M3a1JFRndfQWU2bnJZWldnS3VMbFV2Sms2Y2l4Mjhpc3loUkRpWkdHdzhKZmU0OTFISjhBS3dCZUVJMnF3b1RpbzNVazJHcUxZTEdzN1lpRl9vaGZ5dnJYektqYXA5NjNyNGc?oc=5", "source_name": "Investing.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc. (ALC) Stock Falls on Q4 2025 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxQeGt6MG9RNURrWDNLcnYyMmZHdlRHek1lNGlNeHdsMW03MURpR1FXZzV0WVk3YmMzT2JoeC1INERNWXNwTzdDUm83YkNwNjQtRVlSNkczN1lMenBPbmF6d2FFSUxLQnY0eDVLeWNHcTZOYnVqSkFqb0RFVktZT0tLeXRzYkFCRE1obHBhUXVR?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon shares fall after it cuts guidance and warns of tariff impact", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPQnI2blBka2tJa2Z0b0h5Y1E0NHNrcmJCMVk4RGZIVjI4OERQQlVhOGg0WU5ObUpwM3h1d20ycDNsRnVrVHRvTmMyU1cxWWk1ZS1mdkYtU0JVN1J5c1RLLVlSYzhteHdUVHFjN2JZWTBqVmV4aGN4Tm9QSnE2Tk5QeTBOUUl2YTFnbi1qOWxaYmNyQWJtenVaWld4eUt2cUdP?oc=5", "source_name": "Reuters", "published_at": "2025-08-20T07:00:00+00:00", "published_display": "20 Aug 2025 07:00", "sentiment": "negative", "sentiment_pct": 5, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eyecare company Alcon's shares plunge on revised 2025 outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOMnZyLWRrczBhWmgyQzVJd3NyYW5XY1Byc0pDVDYzQkg4aXRRZDVmZGNpTlJocWFPY2U0UkdjQS1jZ0J6dTkwT1JBX2hsdGpiTTN0UnZnLUR4TGY2N1dPUEpZTjBKclMtQVQzbzBuZkRYT1hUTkpNOXZ6OU1wUnFWTV82cjN0UTNsVjFPU0hvZ29KeE1uWWxKQmc2bjZBek15dDdSNXRpeFpPcUZG?oc=5", "source_name": "Reuters", "published_at": "2025-05-14T07:00:00+00:00", "published_display": "14 May 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon to pay Johnson & Johnson $199 mln to settle eye-laser cases", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPak5zeGF0RE5RVTRfUUxMVXhZdzFQU0F3NnRuNEswN0Q0MTlITGRMUVdHS2ItN081ZVJGTWhnNWNpMXdGVnozSk5qQkdZVUFBWjB5Z2lmLUJiN2taVlJoVWR4NVJEcEtabW9lLXlpRFpxNWRsUHR3cU5hRmxhUWJqV3VrR01xTkdjTEw2SW5BYkN0SDFXbXItY0ZMOWM5LUU?oc=5", "source_name": "Reuters", "published_at": "2023-02-13T08:00:00+00:00", "published_display": "13 Feb 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alcon Inc.: Target Price Consensus and Analysts Recommendations | ALC | CH0432492467", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTE1KdlI1UVhhbE9QdVMyWF90UkZfNjFiSlZPSXByM29qU0p4ME83MHEyMmtTZzlheXlVOGxreFktT0ZQX0xGUkxJTTh2dEJyVGxKQ25PT2RNR28xcjNCUDZnU2lLbkFxNVlOU29aNTMxdDhvbV8zUDhyYzVyTGM?oc=5", "source_name": "marketscreener.com", "published_at": "2020-08-19T09:06:48+00:00", "published_display": "19 Aug 2020 09:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 89, "total_relevant": 42, "sentiment_summary": {"positive": 24, "negative": 3, "neutral": 15, "score": 60, "total": 42, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 12.25, "count": 21}, {"event": "earnings", "label": "Earnings", "weight": 3.3, "count": 6}, {"event": "guidance", "label": "Guidance", "weight": 2.9, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 2.75, "count": 5}, {"event": "macro", "label": "Macro sensitivity", "weight": 2.2, "count": 4}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}], "positive_events": 24, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 67.81, "latest_week": "2026-07-10", "one_week_move": -2.7, "four_week_move": 1.4, "twelve_week_move": -15.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.409472, "market_dynamics_buy_signal": false, "relative_strength": -20.125285, "fair_value_gap": -16.7, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 55.1056, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.7% over one week, +1.4% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 69, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 8}, {"label": "AD HOC NEWS", "count": 6}, {"label": "Ad-hoc-news.de", "count": 3}, {"label": "TradingView", "count": 3}, {"label": "Reuters", "count": 3}, {"label": "GuruFocus", "count": 2}, {"label": "MSN", "count": 2}, {"label": "Stock Titan", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 42}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 21}, {"label": "Earnings", "count": 6}, {"label": "Deals and strategy", "count": 5}, {"label": "Guidance", "count": 4}, {"label": "Macro sensitivity", "count": 4}, {"label": "Analyst action", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "60/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "42", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.7% over one week, +1.4% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Systane Hydration by Alcon Inc. - dry eye relief beyond the pharmacy shelf"}], "updated_at": "2026-07-16T22:51:08.179426+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}